HALF YEARLY RESULTS
Sun Pharmaceutical Industries Ltd.
BSE
Jun 19, 09:51
1647.20
-0.45 ( -0.03%)
Volume
2135
Prev. Close
1647.65
Open Price
1657.15
Bid Price(Qty.)
1645.55 (31)
Offer Pr.(Qty.)
1646.70 (121)
NSE
Jun 19, 09:39
1647.60
-0.40 ( -0.02%)
Volume
110366
Prev. Close
1648.00
Open Price
1648.10
Bid Price(Qty.)
1647.30 (19)
Offer Pr.(Qty.)
1647.60 (47)
You can view the
Halfyearly Results
for the last 5 years.
ISIN No
|
INE044A01036
|
Market Cap. ( ₹ in Cr. )
|
395314.43
|
P/BV
|
5.72
|
Book Value ( ₹ )
|
288.06
|
BSE Code
|
524715
|
52 Week High/Low ( ₹ )
|
1960/1461
|
FV/ML
|
1/1
|
P/E(X)
|
36.17
|
NSE Code
|
SUNPHARMAEQ
|
Book Closure
|
07/07/2025
|
EPS ( ₹ )
|
45.55
|
Div Yield (%)
|
0.97
|
(₹ in Crs.)
Net Sales/Income from operations | 13092.47 | 9625.78 | 10712.89 | 9562.28 | 10350.75 |
Other Operating Income | 285.08 | 0.00 | 0.00 | 0.00 | 243.22 |
Total Income From Operations | 13377.55 | 9625.78 | 10712.89 | 9562.28 | 10593.97 |
| | | | | |
EXPENDITURE | | | | | |
Consumption of Raw Materials | 2492.43 | 2198.24 | 2177.51 | 2251.87 | 2438.62 |
Purchase of Traded Goods | 693.18 | 666.35 | 516.70 | 477.71 | 529.87 |
Increase/Decrease in Stocks | 129.22 | -198.39 | 99.16 | 81.16 | -142.30 |
Employees Cost | 1300.59 | 1307.67 | 1166.10 | 1207.85 | 1055.29 |
Depreciation | 582.93 | 655.34 | 792.64 | 807.98 | 842.42 |
Other Expenses | 4069.20 | 3552.22 | 3500.89 | 3208.61 | 3352.46 |
Total Expenses | 9267.55 | 8181.43 | 8253.00 | 8035.18 | 8076.36 |
| | | | | |
P/L Before Other Inc. , Int., Excpt. Items & Tax | 4110.00 | 1444.35 | 2459.89 | 1527.10 | 2517.61 |
Other Income | 200.39 | 169.04 | 195.68 | 270.08 | 188.33 |
P/L Before Interest, Excpt. Items & Tax | 4310.39 | 1613.39 | 2655.57 | 1797.18 | 2705.94 |
Interest | 433.38 | 459.83 | 432.51 | 351.57 | 292.34 |
P/L Before Exceptional Items & Tax | 3877.01 | 1153.56 | 2223.06 | 1445.61 | 2413.60 |
Exceptional Items | 0.00 | 0.00 | -69.81 | -149.21 | -2937.79 |
P/L Before Tax | 3877.01 | 1153.56 | 2153.25 | 1296.40 | -524.19 |
Tax | 695.50 | 52.45 | 564.34 | 27.13 | 9.90 |
P/L After Tax from Ordinary Activities | 3181.51 | 1101.11 | 1588.91 | 1269.27 | -534.09 |
Net Profit/Loss For the Period | 3181.51 | 1101.11 | 1588.91 | 1269.27 | -534.09 |
| | | | | |
Equity Share Capital | 239.93 | 239.93 | 239.93 | 239.93 | 239.93 |
Reserves And Surplus | 0.00 | 0.00 | 23454.47 | 0.00 | 0.00 |
EPS Before Extra Ordinary * | | | | | |
Basic EPS (Rs.) | 13.26 | 4.60 | 6.62 | 5.30 | -2.23 |
Diluted EPS (Rs.) | 13.26 | 4.60 | 6.62 | 5.30 | (2.23) |
EPS After Extra Ordinary * | | | | | |
Basic EPS (Rs.) | 13.26 | 4.60 | 6.62 | 5.30 | -2.23 |
Diluted EPS (Rs.) | 0.00 | 4.60 | 0.00 | 5.30 | 0.00 |
| | | | | |
PBITOE Margin (%) | 30.72 | 15.00 | 22.96 | 15.97 | 23.76 |
PBTE Margin (%) | 28.98 | 11.98 | 20.75 | 15.11 | 22.78 |
PBT Margin (%) | 28.98 | 11.98 | 20.09 | 13.55 | -4.94 |
PAT Margin (%) | 23.78 | 11.43 | 14.83 | 13.27 | -5.04 |